The Bioinformatics Services Market is Segmented by Service Type (Data Analysis, Database Management, and More), Application (Drug Design & Discovery, Genomics & Proteomics, and More), End User (Pharmaceutical & Biotechnology Companies, and More), Deployment Model (On-Premise and Cloud-Based), and Geography (North America, Europe, Asia-Pacific, and More). The Market Sizes and Forecasts are Provided in Terms of Value (USD).

Bioinformatics Services Market will grow from USD 4,399.58 Million to USD 16,297.10 Million by 2034, showing an impressive CAGR of 15.7%.

Bioinformatics Services Market size was valued at USD 11.1 Billion in 2023 and is projected to reach USD 3.58 Billion by 2031, growing at a CAGR of 15.06% from 2024-2031.

Bioinformatics Services Market: Definition/ Overview

Bioinformatics services cover a wide range of computational tools and methods for managing, analyzing, and interpreting biological data. These services enable the integration of data from domains such as genomics, proteomics, transcriptomics, and metabolomics to provide insights into biological systems. Drug discovery, customized medicine, gene sequencing, and biological data management are some of the most important applications of bioinformatics. Researchers and healthcare professionals use these services to analyze big datasets, detect disease markers, and develop tailored medicines, considerably improving the precision and efficiency of life science research.

According to Cognitive Market Research, the Global Bioinformatics Services Market Size will be USD XX Billion in 2023 and is set to achieve a market size of USD XX Billion by the end of 2031 growing at a CAGR of XX% from 2024 to 2031.

• The global Bioinformatics services Market will expand significantly by XX% CAGR between 2024 and 2031.

• Based on technology, Because of the growing number of platform applications and the need for improved tools for drug development, the bioinformatics platforms segment dominated the market.

• In terms of service type, The sequencing services segment held the largest share and is anticipated to grow over the coming years

• Based on application, The genomic segment dominated the bioinformatics market

• Based on End-user, academic institutes and research centers segment hold the largest share.

• Based on speciality segment, The medical bioinformatics segment holds the large share and is anticipated to expand at a substantial CAGR during the forecast period.

• The North America region accounted for the highest market share in the Global Bioinformatics Services Market. CURRENT SCENARIO OF THE BIOINFORMATICS SERVICES

Driving Factors of the Bioinformatics Services Market

Expansive uses of bioinformatics across multiple sectors is propelling the market's growth.

Several industries, such as the food, bioremediation, agriculture, forensics, and consumer industries, are also using bioinformatics services to improve the quality of their products and supply chain processes. Companies in a variety of sectors are rapidly utilizing bioinformatics services such as data integration, manipulation, lead generation, data management, in silico analysis, and advanced knowledge discovery.

• Bioinformatics Approaches in Food Sciences

In order to meet the needs of food production, food processing, enhancing the quality and nutritional content of food sources, and many other areas, bioinformatics plays a significant role in forecasting and evaluating the intended and undesired impacts of microorganisms on food, genomes, and proteomics research. Furthermore, bioinformatics techniques can be applied to produce crops with high yields and resistance to disease, among other desirable qualities. Additionally, there are numerous databases with information about food, including its components, nutritional value, chemistry, and biology.

Genome Canada is proud to partner with five Institutes where there are five funding pools within this opportunity and Genome Canada is partnering on the Bioinformatics, Computational Biology and Health Data Sciences pool. (Source:https://genomecanada.ca/genome-canada-partners-with-cihr-to-launch-health-research-training-platform-2024-25/)

• Bioinformatics in agriculture

Bioinformatics is becoming more and more crucial in the gathering, storing, and processing of genomic data in the field of agricultural genomics, or agri-genomics. Generally referred to as agri-informatics, some of the various applications of bioinformatics tools and methods in agriculture focus on improving plant resistance against biotic and abiotic stressors as well as enhancing the nutritional quality in depleted soils. Beyond these uses, computer software-assisted gene discovery has enabled researchers to create focused strategies for seed quality enhancement, incorporate extra micronutrients into plants for improved human health, and create plants with phytoremediation potential.

India/UK-based Agri-Genomics startup, Piatrika Biosystems has raised $1.2 Million in a seed round led by Ankur Capital. The company is bringing sustainable seeds and agri chemicals to market faster and cheaper. The investment will be used to build a strong Product Development team, also for more profound research, and to accelerate the productionising and commercialization of MVP. (Source:https://pressroom.icrisat.org/agri-genomics-startup-piatrika-biosystems-raises-12-million-in-seed-funding-led-by-ankur-capital)

This expansion in the application areas of bioinformatics services is likely to drive the overall market growth. Bioinformatics services such as data integration, manipulation, lead discovery, data management, in silico analysis, and advanced knowledge discovery are increasingly being adopted by companies across various industries.&...

Bioinformatics Service Market is will grow to reach USD 12.5 Billion by 2035 and compound yearly growth rate CAGR of 14.70% over the course of the forecast period.

Bioinformatics Services Market size was valued at USD 2.5 billion in 2021 and is poised to grow from USD 2.90 billion in 2022 to USD 8.14 billion by 2030, at a CAGR of 15.9% during the forecast period (2023-2030).

Explore the growth potential of Market Research Intellect's Bioinformatics Services Market Report, valued at USD 12.89 billion in 2024, with a forecasted market size of USD 29.73 billion by 2033, growing at a CAGR of 11.80% from 2026 to 2033.

Global Bioinformatics Services market size is expected to reach $9.38 billion by 2029 at 18.4%, rising adoption of information technology fuels growth in bioinformatics services market

Bioinformatics Services Market Outlook

The global bioinformatics services market size was valued at approximately $2.5 billion in 2023 and is projected to reach roughly $6.8 billion by 2032, growing at a compound annual growth rate (CAGR) of around 11.5%. This impressive growth trajectory is largely driven by the increasing demand for advanced bioinformatics solutions in genomics and proteomics research, the rising prevalence of chronic diseases necessitating personalized medicine, and the growing application of bioinformatics in drug discovery and development processes. Additionally, the integration of artificial intelligence and machine learning in bioinformatics workflows is further accelerating market expansion by enhancing data analysis capabilities and predictive accuracy.

One of the key growth factors in the bioinformatics services market is the exponential rise in biological data generation, fueled by advancements in sequencing technologies and the decreasing cost of genomic sequencing. This surge in data necessitates sophisticated bioinformatics services to manage, analyze, and interpret complex biological information, driving demand across various sectors. Furthermore, the shift towards personalized medicine, where treatments are tailored to individual genetic profiles, is significantly propelling the need for bioinformatics services. These services are pivotal in identifying genetic markers, understanding disease mechanisms, and devising targeted therapeutic strategies, thereby enhancing treatment outcomes.

Another major driver is the expanding role of bioinformatics in drug discovery and development. Pharmaceutical and biotechnology companies are increasingly leveraging bioinformatics to streamline drug development processes, identify potential drug targets, and optimize clinical trials. The integration of bioinformatics into drug development pipelines not only accelerates the discovery of novel therapeutics but also reduces costs and improves the success rates of clinical trials. Moreover, bioinformatics services are crucial in facilitating multi-omics approaches, which integrate genomics, proteomics, transcriptomics, and metabolomics data to provide comprehensive insights into disease pathways and therapeutic responses.

The growing prevalence of chronic diseases, such as cancer, diabetes, and cardiovascular disorders, is another significant factor driving the bioinformatics services market. As the burden of these diseases continues to rise globally, there is an increasing emphasis on developing innovative treatments and diagnostic tools. Bioinformatics services play a crucial role in understanding disease pathogenesis, identifying potential biomarkers, and developing predictive models for disease progression. Additionally, government initiatives and funding to support genomic research and the establishment of biobanks are further bolstering the market, as they create a conducive environment for the adoption of bioinformatics solutions.

Regionally, North America is expected to maintain its dominance in the bioinformatics services market, owing to the presence of a robust healthcare infrastructure, substantial investment in research and development, and the early adoption of advanced technologies. However, the Asia Pacific region is anticipated to witness the highest growth rate over the forecast period, with a CAGR surpassing 13%. This growth is attributed to increasing investments in healthcare infrastructure, a growing focus on precision medicine, and rising government initiatives to support genomic research. The expanding biotechnology industry and the presence of a large patient pool in countries like China and India further contribute to the region's burgeoning market potential.

Service Type Analysis

In the bioinformatics services market, sequencing services represent a critical segment, driven by the increasing adoption of next-generation sequencing (NGS) technologies. These services are essential for the analysis of vast genomic data, enabling researchers to decipher genetic information with unprecedented speed and accuracy. The growing application of sequencing services in personalized medicine, agricultural biotechnology, and infectious disease research is further propelling this segment's growth. As sequencing technologies continue to evolve, there is a substantial demand for bioinformatics services that can efficiently process and interpret the large volumes of data generated, ensuring the segment's robust expansion in the coming years.

Data analysis services form another significant component of the bioinformatics services m

Global Bioinformatics Services market size was USD 3.12 billion in 2023 and is grow to around USD 10.87 billion by 2032 with a CAGR of roughly 14.86%.

Bioinformatics services market size is expected to grow from USD 3.49 bn in 2024 to USD 4.09 bn in 2025 and USD 14.94 bn by 2035, representing a CAGR of 13.8%

The market is segmented into four main types: NGS, chemoinformatics, microarray data analysis, and biological data curation. NGS is the largest segment, accounting for over 50% of the market share. Chemoinformatics is the second largest segment, accounting for around 25% of the market share. Microarray data analysis and biological data curation are the two smallest segments, each accounting for less than 10% of the market share.NGS is used for a variety of applications, including genome sequencing, transcriptome analysis, and whole genome de novo assembly. Chemoinformatics is used for a variety of applications, including drug discovery, molecular modeling, and clinical trial data management. Microarray data analysis is used for a variety of applications, including gene expression analysis and DNA methylation analysis. Biological data curation is used for a variety of applications, including data integration, data annotation, and data storage. Recent developments include: In July 2023, FOXO Technologies launched its Bioinformatics Services, aiming to transform the analysis of epigenetic data. This platform accelerates breakthroughs in biology, biotechnology, and healthcare and redefines the growing field of epigenetic research. This initiative addresses the longstanding challenges in processing, analyzing, and interpreting epigenetic data..

Explore Market Research Intellect's report_name, valued at current_value in 2024, with a projected market growth to forecast_value by 2033, and a CAGR of cagr_value from 2026 to 2033.

Single Cell Bioinformatics Software and Services market by Service, by product, by application & region. Single Cell Bioinformatics Software and Services Market to grow at a significant CAGR 10.89% and projected to reach $634.8 Million by 2031.

The global bioinformatics market is expected to rise from USD 18.7 billion in 2025 to around USD 58.1 billion by 2035, reflecting a CAGR of 12% during the forecast period. The market is undergoing substantial transformation driven by advancements in next-generation sequencing, AI-powered analytics, and rapid data generation from genomics and proteomics.

Exploring Top Countries Driving Innovation, Adoption, and Delivery of Bioinformatics Solutions

Snapshot img

Bioinformatics Market Size 2025-2029

The bioinformatics market size is forecast to increase by USD 15.98 billion, at a CAGR of 17.4% between 2024 and 2029.

The market is experiencing significant growth, driven by the reduction in the cost of genetic sequencing and the development of advanced bioinformatics tools for Next-Generation Sequencing (NGS) technologies. These advancements enable faster and more accurate analysis of genomic data, leading to new discoveries and applications in various industries, including healthcare, agriculture, and research. However, the market faces a major challenge: the shortage of trained laboratory professionals capable of handling and interpreting the vast amounts of data generated by these technologies.
This skills gap poses a significant obstacle to the full realization of the potential of bioinformatics, necessitating strategic investments in workforce development and training programs. Companies seeking to capitalize on the opportunities presented by the market must address this challenge while continuing to innovate and develop sophisticated tools to meet the evolving needs of their customers.

What will be the Size of the Bioinformatics Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free Sample

The market continues to evolve, driven by advancements in genome editing, data mining, and sequence alignment, among other techniques. Molecular modeling and high-throughput screening are essential tools in drug discovery, while bioimage analysis and gene ontology play a pivotal role in systems biology. Metabolomics data and phylogenetic analysis contribute to a deeper understanding of biological processes.

Machine learning and artificial intelligence are increasingly being integrated into bioinformatics pipelines, enabling more accurate predictions of protein structures, disease modeling, and biomarker discovery. Next-generation sequencing and transcriptomics profiling have revolutionized genomic variation studies, leading to a wealth of new insights. For instance, a recent study employing single-cell sequencing and deep learning identified over 60 distinct cell types in the human brain, expanding our knowledge of neurobiology.

The market is expected to grow at a robust rate, with industry experts projecting a 15% annual increase in demand for these advanced analytical solutions. Genome sequencing, epigenomics studies, RNA interference, and proteomics analysis are just a few more applications of bioinformatics, continually pushing the boundaries of scientific discovery. From gene expression to network analysis, the potential applications of bioinformatics are vast and ever-expanding.

How is this Bioinformatics Industry segmented?

The bioinformatics industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Application

  Molecular phylogenetics
  Transcriptomic
  Proteomics
  Metabolomics


Product

  Platforms
  Tools
  Services


End-user

  Pharmaceutical and biotechnology companies
  CROs and research institutes
  Others


Geography

  North America

    US
    Canada
    Mexico


  Europe

    France
    Germany
    Italy
    UK


  APAC

    China
    India
    Japan


  Rest of World (ROW)

By Application Insights

The molecular phylogenetics segment is estimated to witness significant growth during the forecast period.

In the dynamic and innovative realm of bioinformatics, various techniques and tools are propelling research forward. Molecular phylogenetics, a branch of bioinformatics, is a prime example of this progress. This technique, which uses molecular data to explore evolutionary relationships among species, has significantly advanced our understanding of living organisms in fields such as drug discovery, disease diagnosis, and conservation biology.

For instance, molecular phylogenetics plays a pivotal role in studying viral evolution. By analyzing the molecular data of distinct virus strains, researchers can trace their evolution and uncover their origins and transmission patterns. Furthermore, industry growth in bioinformatics is anticipated to expand by approximately 15% annually, as per recent estimates, underscoring the market's continuous evolution and impact.

Request Free Sample

The Molecular phylogenetics segment was valued at USD 4.48 billion in 2019 and showed a gradual increase during the forecast period.

Regional Analysis

North America is estimated to contribute 43% to the growth of the global market during the forecast period.Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the for

The bioinformatics services market, valued at $2987.9 million in 2025, is experiencing robust growth, projected to expand at a compound annual growth rate (CAGR) of 13.8% from 2025 to 2033. This significant expansion is fueled by several key drivers. The accelerating adoption of next-generation sequencing (NGS) technologies in research and clinical settings generates massive datasets requiring sophisticated bioinformatics analysis. Furthermore, the increasing prevalence of chronic diseases necessitates advanced diagnostic tools and personalized medicine approaches, further boosting demand for bioinformatics services. The growing focus on drug discovery and development, particularly in areas like gene therapy and molecular medicine, contributes to market expansion. Academic and research institutions, pharmaceutical and biotechnology companies, and forensic laboratories are major consumers of these services. Specific application areas like drug development and gene therapy are witnessing particularly high growth, driven by technological advancements and increased funding for research. Geographical expansion, particularly in rapidly developing economies in Asia-Pacific and the Middle East & Africa, where infrastructure and research capabilities are growing, contributes to the overall market expansion. However, factors like the high cost of bioinformatics software and expertise, data security concerns, and the need for skilled professionals may act as potential restraints to some extent, though the strong overall growth trends are expected to outweigh these factors. The market segmentation reveals strong growth in the pharmaceutical and biotechnology industries segment driven by the need for efficient drug development pipelines and personalized medicine initiatives. The academic and research centers segment contributes significantly due to ongoing research efforts in genomics and proteomics. Within the types segment, Drug Development and Gene Therapy are showing significant promise, reflecting the industry's focus on novel therapeutic approaches. Leading players like Illumina, Thermo Fisher Scientific, and QIAGEN are driving innovation and market penetration, leading to increased competition and potentially lower pricing in the future. The market’s geographical distribution reflects the higher concentration of research funding and advanced healthcare infrastructure in North America and Europe, with significant growth potential in the Asia Pacific region. The forecast period suggests that the market will continue its upward trajectory, driven by ongoing technological advancements and increasing demand for bioinformatics solutions.

The Single Cell Bioinformatics Software Services Market size is expected to reach a valuation of USD 3.9 billion in 2033 growing at a CAGR of 13.00%. The Single Cell Bioinformatics Software Services Market research report classifies market by share, trend, demand, forecast and based on segmentation.

• Report Overview
• Global Bioinformatics Services Market
• Key Market Segments
• Market Dynamics
• Regional Analysis
• Market Share & Key Players Analysis:

Report Overview

Global Bioinformatics Services’ market value was US$ 2,641 million in 2021, experiencing a CAGR of 15.19%.

The growth of genomics-oriented R&D and the growing use of the technology in drug discovery, biomarker development, and drug discovery are expected to drive this industry. This industry is expected to see significant progress due to a gradual decrease in the costs of DNA sequencing. Read More

The global bioinformatics sequencing services market is experiencing robust growth, driven by the increasing adoption of next-generation sequencing (NGS) technologies in research and clinical applications. The market's expansion is fueled by several key factors, including the falling cost of sequencing, the rising prevalence of genetic disorders requiring advanced diagnostics, and the growing demand for personalized medicine. The application segments, research and clinical, are both contributing significantly to market growth, with research dominating due to the continuous need for genomic research in various fields like oncology, microbiology, and agriculture. Within the types of services, DNA sequencing currently holds a larger market share compared to RNA sequencing, though RNA sequencing is exhibiting faster growth due to its increasing importance in understanding gene expression and regulation. Key players like Illumina, GENEWIZ, and BGI are actively shaping the market landscape through technological innovation and strategic partnerships, fostering competition and driving down costs. The North American and European regions currently dominate the market, but the Asia-Pacific region is expected to witness significant growth in the coming years, driven by increasing investments in healthcare infrastructure and rising awareness of genetic testing in countries like China and India. While regulatory hurdles and data privacy concerns pose challenges, the overall market outlook remains positive, projecting substantial growth over the forecast period. The competitive landscape is characterized by a blend of established players and emerging companies, each vying for market share through technological advancements, strategic acquisitions, and partnerships. The market is witnessing a shift towards cloud-based bioinformatics platforms, providing scalability and accessibility to researchers and clinicians. Furthermore, the integration of artificial intelligence (AI) and machine learning (ML) in bioinformatics analysis is enhancing the speed and accuracy of data interpretation, leading to faster diagnoses and more effective treatment strategies. The increasing demand for comprehensive genomic profiling, coupled with the development of novel sequencing technologies, is expected to further drive market expansion. Although potential restraints exist, such as the high cost of advanced sequencing technologies and the need for specialized expertise in bioinformatics analysis, the overall growth trajectory of the bioinformatics sequencing services market remains strong, promising significant opportunities for players in the industry.